TY - JOUR AU - Coleman, R. E. PY - 2006 DA - 2006// TI - Clinical features of metastatic bone disease and risk of skeletal morbidity JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0931 DO - 10.1158/1078-0432.CCR-06-0931 ID - Coleman2006 ER - TY - JOUR AU - Parker, C. AU - Nilsson, S. AU - Heinrich, D. AU - Helle, S. I. AU - O'Sullivan, J. M. AU - Fosså, S. D. AU - Chodacki, A. AU - Wiechno, P. AU - Logue, J. AU - Seke, M. AU - Widmark, A. AU - Johannessen, D. C. AU - Hoskin, P. AU - Bottomley, D. AU - James, N. D. AU - Solberg, A. AU - Syndikus, I. AU - Kliment, J. AU - Wedel, S. AU - Boehmer, S. AU - Dall'Oglio, M. AU - Franzén, L. AU - Coleman, R. AU - Vogelzang, N. J. AU - O'Bryan-Tear, C. G. AU - Staudacher, K. AU - Garcia-Vargas, J. AU - Shan, M. AU - Bruland, Ø. S. AU - Sartor, O. PY - 2013 DA - 2013// TI - Alpha emitter radium-223 and survival in metastatic prostate cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213755 DO - 10.1056/NEJMoa1213755 ID - Parker2013 ER - TY - JOUR AU - Loblaw, D. A. AU - Wu, J. S. AU - Kirkbride, P. AU - Panzarella, T. AU - Smith, K. AU - Aslanidis, J. AU - Warde, P. PY - 2007 DA - 2007// TI - Pain flare in patients with bone metastases after palliative radiotherapy – a nested randomized control trial JO - Support Care Cancer VL - 15 UR - https://doi.org/10.1007/s00520-006-0166-y DO - 10.1007/s00520-006-0166-y ID - Loblaw2007 ER - TY - STD TI - Chow E, Hoskin P, van der Linden Y, Bottomley A, Velikova G. Quality of life and symptom end points in palliative bone metastases trials. Clin Oncol (R Coll Radiol) 2006;18:67–69. ID - ref4 ER - TY - JOUR AU - Langer, C. AU - Hirsh, V. PY - 2010 DA - 2010// TI - Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates JO - Lung Cancer VL - 67 UR - https://doi.org/10.1016/j.lungcan.2009.08.020 DO - 10.1016/j.lungcan.2009.08.020 ID - Langer2010 ER - TY - JOUR AU - Plunkett, T. A. AU - Smith, P. AU - Rubens, R. D. PY - 2000 DA - 2000// TI - Risk of complications from bone metastases in breast cancer JO - Implications for management Eur J Cancer VL - 36 UR - https://doi.org/10.1016/S0959-8049(99)00331-7 DO - 10.1016/S0959-8049(99)00331-7 ID - Plunkett2000 ER - TY - JOUR AU - Saad, F. AU - Gleason, D. M. AU - Murray, R. AU - Tchekmedyian, S. AU - Venner, P. AU - Lacombe, L. AU - Chin, J. L. AU - Vinholes, J. J. AU - Goas, J. A. AU - Zheng, M. PY - 2004 DA - 2004// TI - Zoledronic Acid Prostate Cancer Study Group: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh141 DO - 10.1093/jnci/djh141 ID - Saad2004 ER - TY - JOUR AU - von Moos, R. AU - Sternberg, C. AU - Body, J. J. AU - Bokemeyer, C. PY - 2013 DA - 2013// TI - Reducing the burden of bone metastases: current concepts and treatment options JO - Support Care Cancer VL - 21 UR - https://doi.org/10.1007/s00520-013-1755-1 DO - 10.1007/s00520-013-1755-1 ID - von Moos2013 ER - TY - JOUR AU - Katzer, A. AU - Meenen, N. M. AU - Grabbe, F. AU - Rueger, J. M. PY - 2002 DA - 2002// TI - Surgery of skeletal metastases JO - Arch Orthop Trauma Surg VL - 122 UR - https://doi.org/10.1007/s00402-001-0359-2 DO - 10.1007/s00402-001-0359-2 ID - Katzer2002 ER - TY - JOUR AU - Rubens, R. D. PY - 1998 DA - 1998// TI - Bone metastases – the clinical problem JO - Eur J Cancer VL - 34 UR - https://doi.org/10.1016/S0959-8049(97)10128-9 DO - 10.1016/S0959-8049(97)10128-9 ID - Rubens1998 ER - TY - JOUR AU - Body, J. J. AU - Chevalier, P. AU - Gunther, O. AU - Hechmati, G. AU - Lamotte, M. PY - 2013 DA - 2013// TI - The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium JO - J Med Econ VL - 16 UR - https://doi.org/10.3111/13696998.2013.774279 DO - 10.3111/13696998.2013.774279 ID - Body2013 ER - TY - JOUR AU - Hechmati, G. AU - Cure, S. AU - Gouépo, A. AU - Hoefeler, H. AU - Lorusso, V. AU - Lüftner, D. AU - Duran, I. AU - Garzon-Rodriguez, C. AU - Ashcroft, J. AU - Wei, R. AU - Ghelani, P. AU - Bahl, A. PY - 2013 DA - 2013// TI - Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study JO - J Med Econ VL - 16 UR - https://doi.org/10.3111/13696998.2013.779921 DO - 10.3111/13696998.2013.779921 ID - Hechmati2013 ER - TY - JOUR AU - Lothgren, M. AU - Ribnicsek, E. AU - Schmidt, L. AU - Habacher, W. AU - Lundkvhist, J. AU - Pfeil, A. M. AU - Biteeva, I. AU - Vrouchou, P. AU - Bracco, A. PY - 2013 DA - 2013// TI - Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland JO - Eur J Hosp Pharm VL - 20 UR - https://doi.org/10.1136/ejhpharm-2012-000235 DO - 10.1136/ejhpharm-2012-000235 ID - Lothgren2013 ER - TY - JOUR AU - Lipton, A. AU - Theriault, R. L. AU - Hortobagyi, G. N. AU - Simeone, J. AU - Knight, R. D. AU - Mellars, K. AU - Reitsma, D. J. AU - Heffernan, M. AU - Seaman, J. J. PY - 2000 DA - 2000// TI - Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Lipton2000 ER - TY - JOUR AU - Rosen, L. S. AU - Gordon, D. AU - Tchekmedyian, N. S. AU - Yanagihara, R. AU - Hirsh, V. AU - Krzakowski, M. AU - Pawlicki, M. AU - De Souza, P. AU - Zheng, M. AU - Urbanowitz, G. AU - Reitsma, D. AU - Seaman, J. PY - 2004 DA - 2004// TI - Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial JO - Cancer VL - 100 UR - https://doi.org/10.1002/cncr.20308 DO - 10.1002/cncr.20308 ID - Rosen2004 ER - TY - JOUR AU - Clemons, M. AU - Gelmon, K. A. AU - Pritchard, K. I. AU - Paterson, A. H. PY - 2012 DA - 2012// TI - Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art JO - Curr Oncol VL - 19 UR - https://doi.org/10.3747/co.19.1011 DO - 10.3747/co.19.1011 ID - Clemons2012 ER - TY - BOOK PY - 2015 DA - 2015// TI - Bondronat® summary of product characteristics ID - ref17 ER - TY - BOOK PY - 2016 DA - 2016// TI - ZOMETA® summary of product characteristics ID - ref18 ER - TY - BOOK PY - 2016 DA - 2016// TI - Pamidronate disodium prescribing information ID - ref19 ER - TY - BOOK PY - 2016 DA - 2016// TI - BONEFOS® summary of product characteristics ID - ref20 ER - TY - JOUR AU - Fizazi, K. AU - Carducci, M. AU - Smith, M. AU - Damião, R. AU - Brown, J. AU - Karsh, L. AU - Milecki, P. AU - Shore, N. AU - Rader, M. AU - Wang, H. AU - Jiang, Q. AU - Tadros, S. AU - Dansey, R. AU - Goessl, C. PY - 2011 DA - 2011// TI - Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(10)62344-6 DO - 10.1016/S0140-6736(10)62344-6 ID - Fizazi2011 ER - TY - JOUR AU - Henry, D. AU - Vadhan-Raj, S. AU - Hirsh, V. AU - von Moos, R. AU - Hungria, V. AU - Costa, L. AU - Woll, P. J. AU - Scagliotti, G. AU - Smith, G. AU - Feng, A. AU - Jun, S. AU - Dansey, R. AU - Yeh, H. PY - 2014 DA - 2014// TI - Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors JO - Support Care Cancer VL - 22 UR - https://doi.org/10.1007/s00520-013-2022-1 DO - 10.1007/s00520-013-2022-1 ID - Henry2014 ER - TY - JOUR AU - Lipton, A. AU - Fizazi, K. AU - Stopeck, A. T. AU - Henry, D. H. AU - Brown, J. E. AU - Yardley, D. A. AU - Richardson, G. E. AU - Siena, S. AU - Maroto, P. AU - Clemens, M. AU - Bilynskyy, B. AU - Charu, V. AU - Beuzeboc, P. AU - Rader, M. AU - Viniegra, M. AU - Saad, F. AU - Ke, C. AU - Braun, A. AU - Jun, S. PY - 2012 DA - 2012// TI - Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.08.002 DO - 10.1016/j.ejca.2012.08.002 ID - Lipton2012 ER - TY - JOUR AU - Stopeck, A. T. AU - Lipton, A. AU - Body, J. J. AU - Steger, G. G. AU - Tonkin, K. AU - de Boer, R. H. AU - Lichinitser, M. AU - Fujiwara, Y. AU - Yardley, D. A. AU - Viniegra, M. AU - Fan, M. AU - Jiang, Q. AU - Dansey, R. AU - Jun, S. AU - Braun, A. PY - 2010 DA - 2010// TI - Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.29.7101 DO - 10.1200/JCO.2010.29.7101 ID - Stopeck2010 ER - TY - JOUR AU - von Moos, R. AU - Body, J. J. AU - Egerdie, B. AU - Stopeck, A. AU - Brown, J. E. AU - Damyanov, D. AU - Fallowfield, L. J. AU - Marx, G. AU - Cleeland, C. S. AU - Patrick, D. L. AU - Palazzo, F. G. AU - Qian, Y. AU - Braun, A. AU - Chung, K. PY - 2013 DA - 2013// TI - Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid JO - Support Care Cancer VL - 21 UR - https://doi.org/10.1007/s00520-013-1932-2 DO - 10.1007/s00520-013-1932-2 ID - von Moos2013 ER - TY - JOUR AU - Arellano, J. AU - Hauber, A. B. AU - Mohamed, A. F. AU - Gonzalez, J. M. AU - Collins, H. AU - Hechmati, G. AU - Gatta, F. AU - Qian, Y. PY - 2015 DA - 2015// TI - Physicians' preferences for bone metastases drug therapy in the United States JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2014.10.004 DO - 10.1016/j.jval.2014.10.004 ID - Arellano2015 ER - TY - JOUR AU - Arellano, J. AU - González, J. M. AU - Qian, Y. AU - Habib, M. AU - Mohamed, A. F. AU - Gatta, F. AU - Hauber, A. B. AU - Posner, J. AU - Califaretti, N. AU - Chow, E. PY - 2015 DA - 2015// TI - Physician preferences for bone metastasis drug therapy in Canada JO - Curr Oncol VL - 22 UR - https://doi.org/10.3747/co.22.2380 DO - 10.3747/co.22.2380 ID - Arellano2015 ER - TY - JOUR AU - Marshall, D. AU - Bridges, J. F. AU - Hauber, B. AU - Cameron, R. AU - Donnalley, L. AU - Fyie, K. AU - Johnson, F. R. PY - 2010 DA - 2010// TI - Conjoint Analysis Applications in Health – How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008 JO - Patient VL - 3 UR - https://doi.org/10.2165/11539650-000000000-00000 DO - 10.2165/11539650-000000000-00000 ID - Marshall2010 ER - TY - JOUR AU - Mohamed, A. F. AU - Hauber, A. B. AU - Neary, M. P. PY - 2011 DA - 2011// TI - Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma JO - Pharmacoeconomics VL - 29 UR - https://doi.org/10.2165/11593370-000000000-00000 DO - 10.2165/11593370-000000000-00000 ID - Mohamed2011 ER - TY - BOOK AU - Hensher, D. A. AU - Rose, J. M. AU - Greene, W. H. PY - 2005 DA - 2005// TI - Applied choice analysis: a primer PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511610356 DO - 10.1017/CBO9780511610356 ID - Hensher2005 ER - TY - BOOK AU - Louviere, J. J. AU - Hensher, D. A. AU - Swait, J. D. PY - 2000 DA - 2000// TI - Stated choice methods: analysis and applications PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511753831 DO - 10.1017/CBO9780511753831 ID - Louviere2000 ER - TY - JOUR AU - Bridges, J. F. AU - Hauber, A. B. AU - Marshall, D. AU - Lloyd, A. AU - Prosser, L. A. AU - Regier, D. A. AU - Johnson, F. R. AU - Mauskopf, J. PY - 2011 DA - 2011// TI - Conjoint analysis applications in health – a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2010.11.013 DO - 10.1016/j.jval.2010.11.013 ID - Bridges2011 ER - TY - BOOK PY - 2016 DA - 2016// TI - XGEVA® prescribing information ID - ref33 ER - TY - BOOK PY - 2015 DA - 2015// TI - ZOMETA® prescribing information ID - ref34 ER - TY - BOOK PY - 2015 DA - 2015// TI - XGEVA® summary of product characteristics ID - ref35 ER - TY - JOUR AU - Jagdev, S. P. AU - Purohit, P. AU - Heatley, S. AU - Herling, C. AU - Coleman, R. E. PY - 2001 DA - 2001// TI - Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease JO - Ann Oncol VL - 12 UR - https://doi.org/10.1023/A:1012506426440 DO - 10.1023/A:1012506426440 ID - Jagdev2001 ER - TY - JOUR AU - Kristensen, B. AU - Ejlertsen, B. AU - Groenvold, M. AU - Hein, S. AU - Loft, H. AU - Mouridsen, H. T. PY - 1999 DA - 1999// TI - Oral clodronate in breast cancer patients with bone metastases: a randomized study JO - J Intern Med VL - 246 UR - https://doi.org/10.1046/j.1365-2796.1999.00507.x DO - 10.1046/j.1365-2796.1999.00507.x ID - Kristensen1999 ER - TY - JOUR AU - Swait, J. AU - Louviere, J. PY - 1993 DA - 1993// TI - The Role of the Scale Parameter in the Estimation and Use of Multinomial Logit Models JO - J Mark Res VL - 30 UR - https://doi.org/10.2307/3172883 DO - 10.2307/3172883 ID - Swait1993 ER - TY - BOOK AU - Train, K. E. PY - 2003 DA - 2003// TI - Discrete choice methods with simulation PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511753930 DO - 10.1017/CBO9780511753930 ID - Train2003 ER - TY - CHAP AU - Train, K. E. AU - Sonnier, G. ED - Scarpa, R. ED - Alberini, A. PY - 2005 DA - 2005// TI - Mixed logit with bounded distributions of correlated partworths BT - Applications of simulation methods in environmental and resource economics PB - Springer CY - Dordrecht ID - Train2005 ER - TY - JOUR AU - Marx, R. E. AU - Sawatari, Y. AU - Fortin, M. AU - Broumand, V. PY - 2005 DA - 2005// TI - Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment JO - J Oral Maxillofac Surg VL - 63 UR - https://doi.org/10.1016/j.joms.2005.07.010 DO - 10.1016/j.joms.2005.07.010 ID - Marx2005 ER - TY - JOUR AU - Polascik, T. J. AU - Mouraviev, V. PY - 2008 DA - 2008// TI - Zoledronic acid in the management of metastatic bone disease JO - Ther Clin Risk Manag VL - 4 UR - https://doi.org/10.2147/TCRM.S2707 DO - 10.2147/TCRM.S2707 ID - Polascik2008 ER - TY - JOUR AU - Saad, F. AU - Brown, J. E. AU - Van Poznak, C. AU - Ibrahim, T. AU - Stemmer, S. M. AU - Stopeck, A. T. AU - Diel, I. J. AU - Takahashi, S. AU - Shore, N. AU - Henry, D. H. AU - Barrios, C. H. AU - Facon, T. AU - Senecal, F. AU - Fizazi, K. AU - Zhou, L. AU - Daniels, A. AU - Carrière, P. PY - 2012 DA - 2012// TI - Dansey Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr435 DO - 10.1093/annonc/mdr435 ID - Saad2012 ER - TY - STD TI - Hechmati G, Arellano J, Mohamed AF, Hauber AB, Qian Y, Gatta F, Haynes I, Bahl A. Patients' preferences for attributes of bone metastases treatments in France, Germany and the United Kingdom. Poster presented at the European Cancer Congress 2013 (ECCO-ESMO-ESTRO), Amsterdam, Netherlands, 2013. ID - ref44 ER - TY - STD TI - Henry DH, von Moos R, Body J-J, Rider A, De Courcy J, Murray G, Bhowmik D, Gatta F, Arellano J, Hechmati G, Roberts Z, Qian Y Bone targeting agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the US Poster presented at the 2015 Breast Cancer Symposium, San Francisco, CA, USA, 2015. ID - ref45 ER -